Selection and monitoring of patients with metastatic castration-resistant prostate cancer for treatment with radium-223 A. Rodriguez-VidaM. D. TorregrosaJ. Carles Review Article 02 November 2017 Pages: 679 - 686
Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) A. BarnadasM. AlgaraT. Fernandez Special Article Open access 14 November 2017 Pages: 687 - 694
Predictive factors of trastuzumab-based chemotherapy in HER2 positive advanced gastric cancer: a single-center prospective observational study Q. LiH. LiT. Liu Research Article 22 November 2017 Pages: 695 - 702
MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer S. GaoH. LiuB. Jiang Research Article 25 October 2017 Pages: 703 - 712
The absolute volume of PET-defined, active bone marrow spared predicts for high grade hematologic toxicity in cervical cancer patients undergoing chemoradiation Y. M. ZhouC. FreeseJ. Kharofa Research Article 26 October 2017 Pages: 713 - 718
No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis T. PengG. ZhaoQ. Wang Research Article 27 October 2017 Pages: 719 - 728
Aggressive intrahepatic therapies for synchronous hepatocellular carcinoma with pulmonary metastasis Z. HuP. HuangH. Zhang Research Article 06 November 2017 Pages: 729 - 739
Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma A. Ernaga-LoreaM. C. Hernández-MorhainA. Irigaray-Echarri Research Article 25 October 2017 Pages: 740 - 744
Transcultural adaptation of the user satisfaction scale to the health service: Brazilian version of the EORTC IN-PATSAT32 questionnaire B. Q. GadelhaC. D. MuziR. M. Guimarães Research Article 30 October 2017 Pages: 745 - 752
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain E. CiruelosM. VidalJ. Gavilá Research Article 07 November 2017 Pages: 753 - 760
Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma J. CaoX. SunD. Chen Research Article 30 October 2017 Pages: 761 - 767
Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial K. ZhouF. WenQ. Li Research Article 02 November 2017 Pages: 768 - 774
LOC285629 regulates cell proliferation and motility in colorectal cancer cells S. N. NasirN. AbuR. Jamal Research Article 02 November 2017 Pages: 775 - 784
Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study M. SuredaJ. RebolloA. Brugarolas Research Article 20 November 2017 Pages: 785 - 793
Revisiting Dukes’ paradigm; some node positive colon cancer patients have better prognosis than some node negative patients O. Abdel-Rahman Brief Research Article 30 October 2017 Pages: 794 - 800
Comment on “Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer” by Lan WG et al. G. YavasC. YavasS. Akyurek Correspondence 23 October 2017 Pages: 801 - 802
Correction to: Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of Primary Care Physicians (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) A. BarnadasM. AlgaraT. Fernandez Correction 02 January 2018 Pages: 803 - 804